Differences in antitumor effects of various statins on human pancreatic cancer.

Differences in antitumor effects of various statins on human pancreatic cancer. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Differences in antitumor effects of various statins on human pancreatic cancer. Abstract Text:

Helena ,Martin ,Jaroslav Zelenka,Zdenek ,Gabriela ,Marie ,Pavla ,Michal Kudla,Peter Balaz, Ruml,Libor ,Helena ,Martin ,Jaroslav Zelenka,Zdenek ,Gabriela ,Marie ,Pavla ,Michal Kudla,Peter Balaz, Ruml,Libor ,

Statins are widely used for the treatment of hypercholesterolemia. However, their inhibitory action on HMG-CoA reductase also results in the depletion of intermediate biosynthetic products, which importantly contribute to cell proliferation. The aim of the present study was to compare the effects of the individual commercially available statins on experimental pancreatic cancer. The in vitro effects of individual statins (pravastatin, atorvastatin, simvastatin, lovastatin, cerivastatin, rosuvastatin and fluvastatin) on the viability of human pancreatic cancer were evaluated in CAPAN-2, BxPc-3 and MiaPaCa-2 cell lines. The in vivo experiments were performed on nude mice xenotransplanted with CAPAN-2 cells. The mice received oral treatments either with a placebo, or with the statins mentioned earlier in a daily dose corresponding to a hypocholesterolemic dose in humans. The effect of these statins on the intracellular Ras protein, trafficking in MiaPaCa-2 transfected cells, was also investigated. Substantial differences in the tumor-suppressive effects of all statins were detected in both in vitro and in vivo experiments. While simvastatin exerted the highest tumor-suppressive effects in vitro, rosuvastatin (p = 0.002), cerivastatin (p = 0.002) and fluvastatin (p = 0.009) were the most potent compounds in an animal model. All statins (except pravastatin) inhibited intracellular Ras protein translocation. In summary, substantial tumor-suppressive effects of various statins on the progression of experimental pancreatic adenocarcinoma were demonstrated, with marked differences among individual statins. These results support greatly the potential of statins for the chemoadjuvant treatment of pancreatic cancer.

Differences in antitumor effects of various statins on human pancreatic cancer. Publishing Authors By Initials

H ,M ,J Zelenka,Z ,G ,M ,P ,M Kudla,P Balaz,T Ruml,L ,H ,M ,J Zelenka,Z ,G ,M ,P ,M Kudla,P Balaz,T Ruml,L ,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Differences in antitumor effects of various statins on human pancreatic cancer. Journal Published:

PUBLICATION TYPE: Research Support, Non-U.S. Gov

Journal: International journal of cancer. Journal internati

VOLUME: 122

Page Numbers: 1214-21

Journal Abbreviation: Int. J. Cancer

ISSN: 1097-0215

DAY: 15

MONTH: Mar

YEAR: 2008

Differences in antitumor effects of various statins on human pancreatic cancer. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 42124

Differences in antitumor effects of various statins on human pancreatic cancer. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Differences in antitumor effects of various statins on human pancreatic cancer. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Differences in antitumor effects of various statins on human pancreatic cancer.

AFFILIATION: Department of Biochemistry and Microbiology and Center for Applied Genomics, Institute of Chemical Technology, Prague, Czech Republic.

Country: United States

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Int J Cancer

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Differences in antitumor effects of various statins on human pancreatic cancer Related Publications

• Accessory meningeal artery: an anatomic misnomer.
• Analytic environment-dependent tight-binding bond integrals: application to MoSi2.
• Angioplasty of arteries in the carotid territory.
• Automatic preparation of computer models.
• COG1410, a novel apolipoprotein E-based peptide, improves functional recovery in a murine model of traumatic brain injury.
• Carotid artery stenting in elderly patients: Importance of case selection.
• Department of Ophthalmology, University of Alabama, School of Medicine, Birmingham.
• Differences in antitumor effects of various statins on human pancreatic cancer.
• Electric field and stimulating influence generated by deep brain stimulation of the subthalamic nucleus.
• Facial reflexes.
• Fatal cerebral hemorrhage early after subclavian artery endovascular therapy.
• Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: Possible protective effects and therapeutic applications of bilirubin.
• Highly sensitive method for quantitative determination of bilirubin in biological fluids and tissues.
• Improved HPLC Analysis of Serum 7{alpha}-Hydroxycholest-4-en-3-one, a Marker of Bile Acid Malabsorption.
• In re: arterial dissection complicating cerebral angiography and cerebrovascular interventions.
• Mechanisms and targets of deep brain stimulation in movement disorders.
• Not Available
• Pallidal burst activity during therapeutic deep brain stimulation.
• Percutaneous transluminal angioplasty of the carotid artery.
• Percutaneous transluminal angioplasty of the external carotid artery.
• Results of percutaneous transluminal angioplasty.
• The persistent effects of unilateral pallidal and subthalamic deep brain stimulation on force control in advanced Parkinson's patients.
• Uncovering the mechanism(s) of action of deep brain stimulation: activation, inhibition, or both.
• [Craniocerebral and medullary cervicogenic syndrome.]
• [EFFECT OF LYSENYL, DESERIL AND OTHER SEROTONIN ANTAGONISTS ON BIOCHEMICAL SYSTEMS.]
• [Expression of presenilin 1 on the cell surface in motile polarized cells]
• [Thrombocytopathia and pseudohaemophilia.]